Objective Evaluation of the Number of Use Hour of Oxygen Therapy in Patients Receiving Supplemental Oxygen
MONOX
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to measure the actual use time in patients receiving supplemental oxygen using a new easy-to-use electronic remote monitoring device (TeleOx™)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2019
CompletedFirst Posted
Study publicly available on registry
December 18, 2019
CompletedStudy Start
First participant enrolled
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedDecember 18, 2019
December 1, 2019
9 months
December 17, 2019
December 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oxygen use time
Average oxygen use time (hours/day) measured with a TeleOx device
15 days
Study Arms (1)
Presentation of the adherence record
OTHERFollowing a first observation period of 15 days, participants whose actual time of use will be less than prescribed will be offered an intervention which will consist of a presentation of the adherence record. The participant will also be asked about the presence of possible barriers concerning the use of oxygen therapy. The collaborator in charge of home visits will attempt to resolve these barriers as much as possible. Only participants with an actual time of use less than prescribed will be offered this intervention and will continue the monitoring over a period of 15 additional days.
Interventions
Adherence record will be presented to participants with an actual time of use less than prescribed. The participant will also be asked about the presence of possible barriers concerning the use of oxygen therapy. The collaborator in charge of home visits will attempt to resolve these barriers as much as possible.
Eligibility Criteria
You may qualify if:
- Oxygen prescription for at least 15 hours/day
You may not qualify if:
- under 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haute Ecole de Santé Vaudlead
- University Hospital, Genevacollaborator
- Ligue Pulmonaire Genevoisecollaborator
Study Sites (1)
Haute Ecole de Santé Vaud (HESAV)
Lausanne, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Contal, PhD
Haute Ecole de Santé Vaud
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ordinary Professor HES
Study Record Dates
First Submitted
December 17, 2019
First Posted
December 18, 2019
Study Start
January 2, 2020
Primary Completion
September 30, 2020
Study Completion
September 30, 2020
Last Updated
December 18, 2019
Record last verified: 2019-12